PHARMAC have announced CGM funding for people with Type 1 diabetes from 1 October 2024.
Learn more - Pharmac announcement
You have nothing in your cart.
If you know the product code enter it here
If you know the product code enter it into the search field
PE anti-human CD304 (Neuropilin-1), 25 tests
PE anti-human CD307d (FcRL4), 100 tests
PE anti-human CD307d (FcRL4), 25 tests
PE anti-human CD307e (FcRL5), 100 tests
PE anti-human CD309 (VEGFR2), 100 tests
PE anti-human CD309 (VEGFR2), 25 tests
PE anti-human CD31, 100 tests
PE anti-human CD31, 25 tests
PE anti-human CD314 (NKG2D), 100 tests
PE anti-human CD314 (NKG2D), 25 tests
PE anti-human CD317 (BST2, Tetherin), 100 tests
PE anti-human CD317 (BST2, Tetherin), 25 tests
PE anti-human CD318 (CDCP1), 100 tests
PE anti-human CD318 (CDCP1), 25 tests
PE anti-human CD319 (CRACC), 100 tests
PE anti-human CD32, 100 tests